Target intelligence / Profile preview

Suppression of tumorigenicity 13 (Hsp70 interacting protein) pseudogene 15 (ST13P15)

Target
ST13P15
Molecular classification
Pseudogene, Other
01

Overview

Suppression of tumorigenicity 13 (Hsp70 interacting protein) pseudogene 15 (ST13P15) is annotated as a human pseudogene corresponding to the functional **ST13** gene, which encodes the Hsp70 interacting protein (Hip), a co-chaperone of heat shock protein 70 (Hsp70)[1][4]. Pseudogenes, including ST13P15, do not produce a functional protein and typically arise from gene duplication or retrotransposition events that then accumulate mutations rendering them non-functional[2]. There is no evidence that ST13P15 itself acts as a therapeutic target, nor is it involved in any known molecular pathways, biological functions, or disease roles; these features distinguish it from the functional ST13 gene, which does play a role in protein homeostasis and possibly tumor suppression but is not directly implicated for ST13P15[2][5]. No drugs, mechanisms of action, or biomarkers are associated with ST13P15, and there are no reported safety concerns[1][2]. **Note:** While the parent gene ST13 has described biological roles (as a co-factor for Hsp70), **ST13P15 is a pseudogene and does not share these properties**. Thus, requests for it as a therapeutic target are considered incorrect or not meaningful in the context of drug discovery or clinical application[2][5].

Other names
ST13P15suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 15
02

Mechanism of action

None

03

Biological functions

Other (Pseudogene; does not encode a functional protein)
04

Disease associations

None established

Beyond the preview

Go deeper on Suppression of tumorigenicity 13 (Hsp70 interacting protein) pseudogene 15 (ST13P15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suppression of tumorigenicity 13 (Hsp70 interacting protein) pseudogene 15 (ST13P15).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call